When the Nutrition Facts label was introduced 20 years ago, fat was the primary concern of the American diet. But as our eating and drinking habits — and knowledge — have shifted, the Food and Drug Administration is making significant changes to these labels. To sort through the details and reasoning for the update Jeffrey Brown talks to former CDC official Dr. William Dietz. Continue reading
The Government Accountability Office has issued a report detailing serious and growing drug shortages in the United States. Sabrina Tavernise of the New York Times joins Hari Sreenivasan from Washington to detail some of the reasons behind the shortfall. Continue reading
The Food and Drug Administration launched an anti-tobacco campaign Tuesday that targets youth and seeks to prevent young people from smoking. The FDA is hoping to educate this age group, between ages 12 and 17, on the harmful effects of smoking through The Real Cost campaign. The campaign plays on some of the more superficial effects of smoking like wrinkles, bad breath and stained teeth.
Recent research suggests that chemicals in antibacterials soaps can interfere with hormone levels and spur the growth of drug-resistant bacteria, prompting the FDA to propose new rules for manufacturers to prove their products are more effective than regular soap and water. Judy Woodruff talks to Elizabeth Weise of USA Today. Continue reading
- NEWSHOUR WEEKEND
New York Times journalist, Sabrina Tavernise, talks to John Larson on new proposals by the Food and Drug Administration that would affect labeling for antibiotics for livestock and would potentially put a halt to the use of growth-promoting drugs in farm animals, and how these new policies might affect human health as well. Continue reading
The battle continues over the emergency contraceptive known as the morning-after pill, as the Justice Department announced it would appeal a federal ruling. A judge had ordered the age restriction be lifted so females of all ages could get the pill without a prescription. Jeffrey Brown talks with NPR’s Julie Rovner.
The Food and Drug Administration on Tuesday approved the first over-the-counter HIV test, which will soon allow Americans to learn whether they’re infected with the virus in the privacy of their homes. Gwen Ifill discusses how the test works and its potential impact with Dr. Anthony Fauci of the National Institutes of Health. Continue reading
The Food and Drug Administration gave the go-ahead Thursday to a drug combination called Truvada that is aimed at preventing the spread of HIV. Until now, it had only approved drugs for treating the disease. Ray Suarez discusses the details with Dr. Anthony Fauci of the National Institute of Allergies and Infectious Diseases. Continue reading
Millions of women grapple with whether to take bone-density-building drugs to treat or prevent osteoporosis, but the FDA this week warned that long-term use of bisphosphonates can lead to rare fractures and side effects. Margaret Warner and Maine Medical Center’s Dr. Clifford Rosen discuss the risks outlined by the FDA. Continue reading
In other news Tuesday, the Supreme Court agreed to revisit affirmative action in college admissions. A white student who was denied entry at the University of Texas in 2008 filed the case, calling the school’s race-conscious policy unconstitutional. Also, federal regulators moved to ease shortages of two cancer drugs. Continue reading